scispace - formally typeset
X

Xin Yu

Researcher at Amgen

Publications -  32
Citations -  4839

Xin Yu is an academic researcher from Amgen. The author has contributed to research in topics: T cell & TIGIT. The author has an hindex of 19, co-authored 27 publications receiving 3517 citations. Previous affiliations of Xin Yu include Rockefeller University & Genentech.

Papers
More filters
Journal ArticleDOI

The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.

TL;DR: The data suggest that TIGIT exerts immunosuppressive effects by binding to poliovirus receptor and modulating cytokine production by dendritic cells.
Journal ArticleDOI

The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function

TL;DR: A key role is defined for TIGIT in inhibiting chronic CD8(+) T cell-dependent responses to tumor formation and chronic immune responses to chronic viral infection.
Journal ArticleDOI

Lineage tracking reveals dynamic relationships of T cells in colorectal cancer.

TL;DR: An integrated RNA-sequencing approach demonstrates that CXCL13+ TH1-like cells are preferentially enriched in microsatellite-instable tumours from patients with colorectal cancer, and IGFLR1 is identified as a co-stimulatory molecule.
Journal ArticleDOI

Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer.

TL;DR: This comprehensive analysis of key myeloid subsets in human and mouse identifies critical cellular interactions regulating tumor immunity and defines mechanisms underlying myeloids-targeted immunotherapies currently undergoing clinical testing.
Journal ArticleDOI

The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression

TL;DR: The results show that the BRCT domains interact in vivo with CtIP, a protein originally identified on the basis of its association with the CtBP transcriptional co-repressor, suggesting that BRCA1 regulates gene expression, at least in part, by modulating CtBP-mediated transcriptional repression.